Supernus Pharmaceuticals Stock Forward View - Accumulation Distribution
| SUPN Stock | USD 49.08 0.68 1.40% |
Supernus Stock outlook is based on your current time horizon. Although Supernus Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Supernus Pharmaceuticals' systematic risk associated with finding meaningful patterns of Supernus Pharmaceuticals fundamentals over time.
As of today, the relative strength index (RSI) of Supernus Pharmaceuticals' share price is approaching 49. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Supernus Pharmaceuticals, making its price go up or down. Momentum 49
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 0.111 | EPS Estimate Next Quarter 0.735 | EPS Estimate Current Year 2.625 | EPS Estimate Next Year 2.495 | Wall Street Target Price 61.3333 |
Using Supernus Pharmaceuticals hype-based prediction, you can estimate the value of Supernus Pharmaceuticals from the perspective of Supernus Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Supernus Pharmaceuticals using Supernus Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Supernus using crowd psychology based on the activity and movement of Supernus Pharmaceuticals' stock price.
Supernus Pharmaceuticals Short Interest
An investor who is long Supernus Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Supernus Pharmaceuticals and may potentially protect profits, hedge Supernus Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 41.952 | Short Percent 0.1015 | Short Ratio 6.46 | Shares Short Prior Month 4.4 M | 50 Day MA 48.5522 |
Supernus Relative Strength Index
Supernus Pharmaceuticals Hype to Price Pattern
Investor biases related to Supernus Pharmaceuticals' public news can be used to forecast risks associated with an investment in Supernus. The trend in average sentiment can be used to explain how an investor holding Supernus can time the market purely based on public headlines and social activities around Supernus Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Supernus Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Supernus Pharmaceuticals.
Supernus Pharmaceuticals Implied Volatility | 0.69 |
Supernus Pharmaceuticals' implied volatility exposes the market's sentiment of Supernus Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Supernus Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Supernus Pharmaceuticals stock will not fluctuate a lot when Supernus Pharmaceuticals' options are near their expiration.
Supernus Pharmaceuticals after-hype prediction price | USD 49.11 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Supernus Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Supernus contract
Based on the Rule 16, the options market is currently suggesting that Supernus Pharmaceuticals will have an average daily up or down price movement of about 0.0431% per day over the life of the 2026-03-20 option contract. With Supernus Pharmaceuticals trading at USD 49.08, that is roughly USD 0.0212 . If you think that the market is fully incorporating Supernus Pharmaceuticals' daily price movement you should consider acquiring Supernus Pharmaceuticals options at the current volatility level of 0.69%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Supernus Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Supernus Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Supernus Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Supernus Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Supernus Pharmaceuticals' open interest, investors have to compare it to Supernus Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Supernus Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Supernus. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Supernus Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Supernus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Supernus using various technical indicators. When you analyze Supernus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 37654.2 | 17080.79 |
| Check Supernus Pharmaceuticals Volatility | Backtest Supernus Pharmaceuticals | Information Ratio |
Supernus Pharmaceuticals Trading Date Momentum
| On February 04 2026 Supernus Pharmaceuticals was traded for 49.08 at the closing time. The top price for the day was 49.47 and the lowest listed price was 48.20 . The trading volume for the day was 665.3 K. The trading history from February 4, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 1.34% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Supernus Pharmaceuticals to competition |
Other Forecasting Options for Supernus Pharmaceuticals
For every potential investor in Supernus, whether a beginner or expert, Supernus Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Supernus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Supernus. Basic forecasting techniques help filter out the noise by identifying Supernus Pharmaceuticals' price trends.Supernus Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Supernus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Supernus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Supernus Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Supernus Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Supernus Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Supernus Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Supernus Pharmaceuticals stock market strength indicators, traders can identify Supernus Pharmaceuticals entry and exit signals to maximize returns.
Supernus Pharmaceuticals Risk Indicators
The analysis of Supernus Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Supernus Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting supernus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.49 | |||
| Standard Deviation | 2.68 | |||
| Variance | 7.19 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Supernus Pharmaceuticals
The number of cover stories for Supernus Pharmaceuticals depends on current market conditions and Supernus Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Supernus Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Supernus Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Supernus Pharmaceuticals Short Properties
Supernus Pharmaceuticals' future price predictability will typically decrease when Supernus Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Supernus Pharmaceuticals often depends not only on the future outlook of the potential Supernus Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Supernus Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 56 M | |
| Cash And Short Term Investments | 453.6 M |
Check out Historical Fundamental Analysis of Supernus Pharmaceuticals to cross-verify your projections. To learn how to invest in Supernus Stock, please use our How to Invest in Supernus Pharmaceuticals guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Pharmaceuticals sector continue expanding? Could Supernus diversify its offerings? Factors like these will boost the valuation of Supernus Pharmaceuticals. If investors know Supernus will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Supernus Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.111 | Earnings Share (0.34) | Revenue Per Share | Quarterly Revenue Growth 0.093 | Return On Assets |
The market value of Supernus Pharmaceuticals is measured differently than its book value, which is the value of Supernus that is recorded on the company's balance sheet. Investors also form their own opinion of Supernus Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Supernus Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Supernus Pharmaceuticals' market value can be influenced by many factors that don't directly affect Supernus Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Supernus Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Supernus Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Supernus Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.